Latest News

Granada, Spain – Research carried out by the UGR, IDIBELL, the Catalan Institute of Oncology and the Biohealth Research Institute in Granada (ibs.GRANADA), published in the journal Environmental Health Perspectives, has revealed a link between environmental pollutants and endometrial cancer. The collaborative study involved scientists and doctors from Bellvitge University...
Bethesda, Maryland – The drug minocycline, an antibiotic that also decreases inflammation, failed to slow vision loss or expansion of geographic atrophy in people with dry age-related macular degeneration (AMD), according to a phase II clinical study at the National Eye Institute (NEI), part of the National Institutes of Health....
Ann Arbor, Mich. – Participation in recreational activities — including golfing, gardening or yard work, woodworking and hunting — may be associated with an increase in a person’s risk for developing amyotrophic lateral sclerosis, or ALS, a Michigan Medicine study finds. While many activities were associated with increased ALS risk,...
BURTON, Ohio — The first signs that something was wrong with 11-year-old Connor Teare came when he was a toddler. His muscles were growing increasingly rigid and becoming more difficult to move. He went from leg braces to a walker and, finally, a wheelchair by the time he was 5....
WASHINGTON, DC  — In a first-of-its-kind clinical trial, researchers found that intravenous therapies made from virus-specific T-cells (VST) can effectively treat immunocompromised pediatric patients, far surpassing the current standard of care, according to new research published in Nature Communications. More than 60% of patients in the phase 2 clinical trial...
Helsinki, Finland – A multidisciplinary team of scientists led by University of Helsinki report that a progressive neurodegenerative disease can be triggered by a viral infection. The mechanism relates to mitochondrial roles in antiviral defense mechanisms. The scientists report that a specific gene variant affecting the mitochondria disturb cellular antiviral...